Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: E9ANT0
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 46 | 48 | PF00675 | 0.471 |
CLV_NRD_NRD_1 | 7 | 9 | PF00675 | 0.586 |
CLV_PCSK_FUR_1 | 4 | 8 | PF00082 | 0.643 |
CLV_PCSK_KEX2_1 | 20 | 22 | PF00082 | 0.424 |
CLV_PCSK_KEX2_1 | 3 | 5 | PF00082 | 0.545 |
CLV_PCSK_KEX2_1 | 46 | 48 | PF00082 | 0.471 |
CLV_PCSK_KEX2_1 | 6 | 8 | PF00082 | 0.529 |
CLV_PCSK_PC1ET2_1 | 20 | 22 | PF00082 | 0.490 |
CLV_PCSK_PC1ET2_1 | 3 | 5 | PF00082 | 0.600 |
CLV_PCSK_PC1ET2_1 | 6 | 8 | PF00082 | 0.576 |
CLV_PCSK_SKI1_1 | 69 | 73 | PF00082 | 0.542 |
CLV_PCSK_SKI1_1 | 8 | 12 | PF00082 | 0.626 |
DEG_APCC_DBOX_1 | 32 | 40 | PF00400 | 0.557 |
DOC_MAPK_MEF2A_6 | 78 | 87 | PF00069 | 0.531 |
DOC_MAPK_NFAT4_5 | 78 | 86 | PF00069 | 0.455 |
DOC_MAPK_RevD_3 | 34 | 47 | PF00069 | 0.476 |
DOC_PP2B_LxvP_1 | 102 | 105 | PF13499 | 0.477 |
DOC_USP7_MATH_1 | 49 | 53 | PF00917 | 0.564 |
DOC_USP7_MATH_1 | 89 | 93 | PF00917 | 0.547 |
DOC_WW_Pin1_4 | 23 | 28 | PF00397 | 0.542 |
DOC_WW_Pin1_4 | 69 | 74 | PF00397 | 0.597 |
LIG_14-3-3_CanoR_1 | 33 | 37 | PF00244 | 0.460 |
LIG_APCC_ABBA_1 | 81 | 86 | PF00400 | 0.464 |
LIG_APCC_ABBA_1 | 91 | 96 | PF00400 | 0.369 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.636 |
LIG_BRCT_BRCA1_1 | 91 | 95 | PF00533 | 0.475 |
LIG_FHA_1 | 7 | 13 | PF00498 | 0.553 |
LIG_FHA_1 | 75 | 81 | PF00498 | 0.452 |
LIG_KLC1_Yacidic_2 | 82 | 86 | PF13176 | 0.445 |
LIG_LIR_Gen_1 | 82 | 91 | PF02991 | 0.422 |
LIG_LIR_Nem_3 | 52 | 56 | PF02991 | 0.537 |
LIG_LIR_Nem_3 | 82 | 87 | PF02991 | 0.438 |
LIG_MLH1_MIPbox_1 | 91 | 95 | PF16413 | 0.475 |
LIG_PCNA_TLS_4 | 78 | 85 | PF02747 | 0.455 |
LIG_SH2_CRK | 40 | 44 | PF00017 | 0.645 |
LIG_SH2_CRK | 53 | 57 | PF00017 | 0.557 |
LIG_SH2_SRC | 23 | 26 | PF00017 | 0.510 |
LIG_SH2_SRC | 84 | 87 | PF00017 | 0.535 |
LIG_SH2_STAP1 | 44 | 48 | PF00017 | 0.579 |
LIG_SH2_STAT5 | 40 | 43 | PF00017 | 0.368 |
LIG_SH2_STAT5 | 84 | 87 | PF00017 | 0.535 |
LIG_SH2_STAT5 | 94 | 97 | PF00017 | 0.516 |
LIG_SUMO_SIM_par_1 | 99 | 106 | PF11976 | 0.486 |
LIG_WRC_WIRS_1 | 68 | 73 | PF05994 | 0.594 |
LIG_WW_1 | 37 | 40 | PF00397 | 0.563 |
MOD_CK1_1 | 74 | 80 | PF00069 | 0.584 |
MOD_GSK3_1 | 67 | 74 | PF00069 | 0.494 |
MOD_NEK2_2 | 89 | 94 | PF00069 | 0.474 |
MOD_PKA_1 | 6 | 12 | PF00069 | 0.651 |
MOD_PKA_2 | 32 | 38 | PF00069 | 0.489 |
MOD_PKA_2 | 6 | 12 | PF00069 | 0.559 |
MOD_Plk_4 | 89 | 95 | PF00069 | 0.465 |
MOD_ProDKin_1 | 23 | 29 | PF00069 | 0.539 |
MOD_ProDKin_1 | 69 | 75 | PF00069 | 0.599 |
TRG_DiLeu_BaEn_1 | 86 | 91 | PF01217 | 0.414 |
TRG_ENDOCYTIC_2 | 40 | 43 | PF00928 | 0.642 |
TRG_ENDOCYTIC_2 | 53 | 56 | PF00928 | 0.553 |
TRG_ENDOCYTIC_2 | 84 | 87 | PF00928 | 0.540 |
TRG_NES_CRM1_1 | 82 | 96 | PF08389 | 0.510 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I3B4 | Leptomonas seymouri | 78% | 100% |
A0A1X0NM04 | Trypanosomatidae | 33% | 100% |
A0A3Q8IHL3 | Leishmania donovani | 98% | 100% |
A0A422N6I2 | Trypanosoma rangeli | 39% | 100% |
A4H6R9 | Leishmania braziliensis | 89% | 100% |
C9ZQD7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 100% |
E9AGA3 | Leishmania infantum | 98% | 100% |
Q4QGT9 | Leishmania major | 97% | 100% |